chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Escherichia bacteraemia, Fatigue, Hypotension, Inflammatory marker increased
Clinical narrative: Discharge Provider:  MD; Primary Care Provider: DO; Admission Date: 8/22/2022; Discharge Date: Aug 25, 2022 PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Sixty-nine year old male with past medical history significant for obesity, nonambulatory at baseline, hypertension, hyperlipidemia, recent admissions for E coli bacteremia related to diskitis/osteomyelitis from L3-S1 as well as suspected vertebral abscess at the level of S1 that was drained.  He was readmitted in May for altered mental status found to have large gluteal abscess was also drained.  He presents to emergency department on 08/22 with worsening fatigue and lethargy.  He is mildly hypotensive on admission and otherwise stable.  Labs were notable for elevated inflammatory markers.  He did test positive for COVID-19.  His checks x-ray was normal.  Admitted to Medicine Service further assessment and management. As far as COVID-19 goes, patient was treated supportively.  He did not develop respiratory failure and did not require steroids or other treatments.  Improved over the course of the days he was hospitalized. In regards to his hypotension, this resolved with IV fluids.  We did switch his home Lasix to p.r.n. basis.  Blood pressure normalized by the day of discharge. Patient was on Coumadin for history of DVT.  This was continued in the hospital setting and started on a bridge with Lovenox which he will continue at his facility for  infra-therapeutic INR. Interventional Radiology and surgical specialist evaluated patient is drains from prior diskitis/osteomyelitis and gluteal abscess.  Blood cultures were obtained and remained negative.  It did not feel there was any issue with the drains and recommended outpatient follow-up. Patient is discharged back to his facility in stable and improved condition.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Intervertebral discitis, Laboratory test abnormal, Lethargy, Mental status changes, Osteomyelitis
Clinical narrative: Discharge Provider:  MD; Primary Care Provider: DO; Admission Date: 8/22/2022; Discharge Date: Aug 25, 2022 PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Sixty-nine year old male with past medical history significant for obesity, nonambulatory at baseline, hypertension, hyperlipidemia, recent admissions for E coli bacteremia related to diskitis/osteomyelitis from L3-S1 as well as suspected vertebral abscess at the level of S1 that was drained.  He was readmitted in May for altered mental status found to have large gluteal abscess was also drained.  He presents to emergency department on 08/22 with worsening fatigue and lethargy.  He is mildly hypotensive on admission and otherwise stable.  Labs were notable for elevated inflammatory markers.  He did test positive for COVID-19.  His checks x-ray was normal.  Admitted to Medicine Service further assessment and management. As far as COVID-19 goes, patient was treated supportively.  He did not develop respiratory failure and did not require steroids or other treatments.  Improved over the course of the days he was hospitalized. In regards to his hypotension, this resolved with IV fluids.  We did switch his home Lasix to p.r.n. basis.  Blood pressure normalized by the day of discharge. Patient was on Coumadin for history of DVT.  This was continued in the hospital setting and started on a bridge with Lovenox which he will continue at his facility for  infra-therapeutic INR. Interventional Radiology and surgical specialist evaluated patient is drains from prior diskitis/osteomyelitis and gluteal abscess.  Blood cultures were obtained and remained negative.  It did not feel there was any issue with the drains and recommended outpatient follow-up. Patient is discharged back to his facility in stable and improved condition.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Discharge Provider:  MD; Primary Care Provider: DO; Admission Date: 8/22/2022; Discharge Date: Aug 25, 2022 PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Sixty-nine year old male with past medical history significant for obesity, nonambulatory at baseline, hypertension, hyperlipidemia, recent admissions for E coli bacteremia related to diskitis/osteomyelitis from L3-S1 as well as suspected vertebral abscess at the level of S1 that was drained.  He was readmitted in May for altered mental status found to have large gluteal abscess was also drained.  He presents to emergency department on 08/22 with worsening fatigue and lethargy.  He is mildly hypotensive on admission and otherwise stable.  Labs were notable for elevated inflammatory markers.  He did test positive for COVID-19.  His checks x-ray was normal.  Admitted to Medicine Service further assessment and management. As far as COVID-19 goes, patient was treated supportively.  He did not develop respiratory failure and did not require steroids or other treatments.  Improved over the course of the days he was hospitalized. In regards to his hypotension, this resolved with IV fluids.  We did switch his home Lasix to p.r.n. basis.  Blood pressure normalized by the day of discharge. Patient was on Coumadin for history of DVT.  This was continued in the hospital setting and started on a bridge with Lovenox which he will continue at his facility for  infra-therapeutic INR. Interventional Radiology and surgical specialist evaluated patient is drains from prior diskitis/osteomyelitis and gluteal abscess.  Blood cultures were obtained and remained negative.  It did not feel there was any issue with the drains and recommended outpatient follow-up. Patient is discharged back to his facility in stable and improved condition.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood electrolytes, Blood sodium decreased, Blood thyroid stimulating hormone abnormal, COVID-19
Clinical narrative: Discharge Physician: Primary Care Physician: Date of Admission: 8/22/2022; Discharge Date: 8/24/2022; Room Number: 2020/2020-1; PRESENTING PROBLEM: Weakness [R53.1]; Generalized weakness [R53.1]; COVID-19 [U07.1]HOSPITAL COURSE:A 79 y.o. female who presents today with weakness and fatigue. The patient is somewhat forgetful and cannot give many details about duration of symptoms. She reports that she started feeling ill two days ago however was seen in the ER at Hospital on 8/18 with report of symptoms starting a day or so before this visit. She has been having significant fatigue, weakness, a cough, sore throat and poor appetite. Many of her family members have had COVID. She tested positive on a home test and was given a prescription for paxlovid in the ER on 8/18. Her husband was admitted to the hospital last night and son had concerns about the patient's ability to care for herself at home so she was brought to the ER for evaluation.  In the ER the patient had labs which were mostly unremarkable. Her sodium was a bit lower than her recent baseline at 128. She was COVID positive. Her CXR was negative. She was not hypoxic. She was admitted to the hospitalist team for PT/OT evaluation and possible placement.  She was continued on IV fluid with improvement of sodium.  PT/OT evaluated advised home health PT/OT and return to assisted living.  Patient unable to return to assisted living until completion of quarantine for which patient's family was agreeable to watching her patient and spouse until end quarantine. Electrolytes were monitored and repleted PRN throughout the admission. TFTs were updated and she had notable improvement of TSH. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Cough, Decreased appetite, Electrolyte substitution therapy, Fatigue
Clinical narrative: Discharge Physician: Primary Care Physician: Date of Admission: 8/22/2022; Discharge Date: 8/24/2022; Room Number: 2020/2020-1; PRESENTING PROBLEM: Weakness [R53.1]; Generalized weakness [R53.1]; COVID-19 [U07.1]HOSPITAL COURSE:A 79 y.o. female who presents today with weakness and fatigue. The patient is somewhat forgetful and cannot give many details about duration of symptoms. She reports that she started feeling ill two days ago however was seen in the ER at Hospital on 8/18 with report of symptoms starting a day or so before this visit. She has been having significant fatigue, weakness, a cough, sore throat and poor appetite. Many of her family members have had COVID. She tested positive on a home test and was given a prescription for paxlovid in the ER on 8/18. Her husband was admitted to the hospital last night and son had concerns about the patient's ability to care for herself at home so she was brought to the ER for evaluation.  In the ER the patient had labs which were mostly unremarkable. Her sodium was a bit lower than her recent baseline at 128. She was COVID positive. Her CXR was negative. She was not hypoxic. She was admitted to the hospitalist team for PT/OT evaluation and possible placement.  She was continued on IV fluid with improvement of sodium.  PT/OT evaluated advised home health PT/OT and return to assisted living.  Patient unable to return to assisted living until completion of quarantine for which patient's family was agreeable to watching her patient and spouse until end quarantine. Electrolytes were monitored and repleted PRN throughout the admission. TFTs were updated and she had notable improvement of TSH. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Malaise, Memory impairment, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Discharge Physician: Primary Care Physician: Date of Admission: 8/22/2022; Discharge Date: 8/24/2022; Room Number: 2020/2020-1; PRESENTING PROBLEM: Weakness [R53.1]; Generalized weakness [R53.1]; COVID-19 [U07.1]HOSPITAL COURSE:A 79 y.o. female who presents today with weakness and fatigue. The patient is somewhat forgetful and cannot give many details about duration of symptoms. She reports that she started feeling ill two days ago however was seen in the ER at Hospital on 8/18 with report of symptoms starting a day or so before this visit. She has been having significant fatigue, weakness, a cough, sore throat and poor appetite. Many of her family members have had COVID. She tested positive on a home test and was given a prescription for paxlovid in the ER on 8/18. Her husband was admitted to the hospital last night and son had concerns about the patient's ability to care for herself at home so she was brought to the ER for evaluation.  In the ER the patient had labs which were mostly unremarkable. Her sodium was a bit lower than her recent baseline at 128. She was COVID positive. Her CXR was negative. She was not hypoxic. She was admitted to the hospitalist team for PT/OT evaluation and possible placement.  She was continued on IV fluid with improvement of sodium.  PT/OT evaluated advised home health PT/OT and return to assisted living.  Patient unable to return to assisted living until completion of quarantine for which patient's family was agreeable to watching her patient and spouse until end quarantine. Electrolytes were monitored and repleted PRN throughout the admission. TFTs were updated and she had notable improvement of TSH. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroid function test
Clinical narrative: Discharge Physician: Primary Care Physician: Date of Admission: 8/22/2022; Discharge Date: 8/24/2022; Room Number: 2020/2020-1; PRESENTING PROBLEM: Weakness [R53.1]; Generalized weakness [R53.1]; COVID-19 [U07.1]HOSPITAL COURSE:A 79 y.o. female who presents today with weakness and fatigue. The patient is somewhat forgetful and cannot give many details about duration of symptoms. She reports that she started feeling ill two days ago however was seen in the ER at Hospital on 8/18 with report of symptoms starting a day or so before this visit. She has been having significant fatigue, weakness, a cough, sore throat and poor appetite. Many of her family members have had COVID. She tested positive on a home test and was given a prescription for paxlovid in the ER on 8/18. Her husband was admitted to the hospital last night and son had concerns about the patient's ability to care for herself at home so she was brought to the ER for evaluation.  In the ER the patient had labs which were mostly unremarkable. Her sodium was a bit lower than her recent baseline at 128. She was COVID positive. Her CXR was negative. She was not hypoxic. She was admitted to the hospitalist team for PT/OT evaluation and possible placement.  She was continued on IV fluid with improvement of sodium.  PT/OT evaluated advised home health PT/OT and return to assisted living.  Patient unable to return to assisted living until completion of quarantine for which patient's family was agreeable to watching her patient and spouse until end quarantine. Electrolytes were monitored and repleted PRN throughout the admission. TFTs were updated and she had notable improvement of TSH. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 1.08
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Parent requested Moderna series on the admission paperwork,  Pfizer (correct pediatric dosage) was given instead
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Full blood count, Immunoglobulin therapy, Petechiae, Platelet count decreased
Clinical narrative: Two days after receiving the Moderna booster shot I developed bruising and petechiae on my hands, wrists and lower extremities.  These were my symptoms when I was initially diagnosed with ITP in 2013 (which I still maintain was caused my travel vaccines - yellow fever, Typhoid and Hepatitis A)   It got worse over the next day so I went to the local ER and found that my platelets dropped to 8,000.  I was admitted to the hospital and received two 80g infusions of IVIG and a 4 day course of decadron.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Cough, Feeling abnormal, Infusion
Clinical narrative: I tested positive for COVID-19. I had a slight cough; hip aches; felt crummy. I talked to the doctor and got an infusion. My symptoms lasted for 4 days.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19. I had a slight cough; hip aches; felt crummy. I talked to the doctor and got an infusion. My symptoms lasted for 4 days.
Age: 19.0
Sex: M
Vaccine: HEPA
Symptoms: No adverse event
Clinical narrative: No adverse reaction
Age: 1.17
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Pt was inadvertnatly give Pfizer 2nd dose after Moderna initial dose.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Moderna vaccine administered was  beyond the manufacturer recommended use time of 30 days at the refrigerated temperature.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given vaccine that was beyond its use date of 7/22/2022
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Chest pain, Echocardiogram normal, Electrocardiogram normal, SARS-CoV-2 test positive
Clinical narrative: Primary Care Physician at Discharge: Medical doctor. Admission Date: 8/23/2022 Discharge Date: 8/23/22  PRESENTING PROBLEM: Elevated troponin   HOSPITAL COURSE: The patient is a 15 y.o. who presented to hospital with sharp chest pain exacerbated with breathing a few hours after sport practice and found to have mildly elevated troponin levels.  Subsequently found to be COVID positive. He was transferred to other hospital for further evaluation. Chest pain on further evaluation aligned with musculoskeletal etiology. His EKG obtained here showed no changes and he had a normal echocardiogram. Troponins have returned to normal from elevation at outside hospital. He had no elevation in his inflammatory markers to support inflammation from myocarditis. Overall, it is unlikely this patient currently has myocarditis. He currently presents with an asymptomatic COVID infection. Based on our evaluation we determined that patient did not require any further hospitalization. Will be discharge home to follow up with his PCP should COVID symptoms progress.     Labs reviewed from last 24 hours
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Primary Care Physician at Discharge: Medical doctor. Admission Date: 8/23/2022 Discharge Date: 8/23/22  PRESENTING PROBLEM: Elevated troponin   HOSPITAL COURSE: The patient is a 15 y.o. who presented to hospital with sharp chest pain exacerbated with breathing a few hours after sport practice and found to have mildly elevated troponin levels.  Subsequently found to be COVID positive. He was transferred to other hospital for further evaluation. Chest pain on further evaluation aligned with musculoskeletal etiology. His EKG obtained here showed no changes and he had a normal echocardiogram. Troponins have returned to normal from elevation at outside hospital. He had no elevation in his inflammatory markers to support inflammation from myocarditis. Overall, it is unlikely this patient currently has myocarditis. He currently presents with an asymptomatic COVID infection. Based on our evaluation we determined that patient did not require any further hospitalization. Will be discharge home to follow up with his PCP should COVID symptoms progress.     Labs reviewed from last 24 hours
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: A 5-11 covid-19 vaccine was administered to a 3 year old, no adverse event.
Age: 31.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Dizziness, Eye movement disorder, Loss of consciousness
Clinical narrative: Pt. received 1st dose of Jynneos Monkeypox Vaccine, intramuscular, at 1542 on 08/26/22. Pt.  proceeded to observation area and began to feel lightheaded and dizzy at approximately 1555. Per  observation staff, pt. stated he needed to lie down, and began to lose consciousness at that time for up to 10 seconds. Eye rolling to back of head was noted. Observation staff performed sternal rub and pt. became responsive. PH nurses notified. VS taken: BP 90/54, Temp. 98.6. EMS notified; both Fire and EMS responded. Pt.s' VS stable upon 2nd set. Pt. declined ER treatment. Pt. remained in observation, drank water and juice, and ate a protein bar. Pt. able to depart without incident at approximately 1630. Observation staff provided contact number for pt. to call upon arriving home.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Moderna vaccine given was beyond the manufacturer recommended use time of 30 days at the refrigerated temperature.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium abnormal, Condition aggravated, Confusional state, Generalised oedema, Hepatic cirrhosis
Clinical narrative: Discharge Provider: Private MD Primary Care Provider: Private MD Admission Date: 8/23/2022 Discharge Date: 8/25/2022  Clinical Narrative: The patient is 49-year-old with advanced cirrhosis who is being seen at the local hospital and at the transplant center for hopeful eventual entry into a transplant program for hopeful eventual candidacy. He has 7 months of sobriety from alcohol under his belt at present. He was noted to be significantly hyponatremic. He may have had some mild confusion with this foot likely has grade 1 hepatic encephalopathy as well. He was noted to be grossly edematous with anasarca from decompensated acute on chronic cirrhosis without actual coma. He was diuresed accordingly with improvement in his serum sodium and clinical exam. He did not require other interventions. He was noted to have suffered from COVID recently but is improving and just beyond the dating were PACs lobe it may have been indicated. This continued to do well. He is being discharged home today with the caveats that he is requesting early discharge as he is in the process of being evicted from his apartment. Have asked him to seek repeat labs within 1 week.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatic encephalopathy, Hyponatraemia, Oedema, Polyuria
Clinical narrative: Discharge Provider: Private MD Primary Care Provider: Private MD Admission Date: 8/23/2022 Discharge Date: 8/25/2022  Clinical Narrative: The patient is 49-year-old with advanced cirrhosis who is being seen at the local hospital and at the transplant center for hopeful eventual entry into a transplant program for hopeful eventual candidacy. He has 7 months of sobriety from alcohol under his belt at present. He was noted to be significantly hyponatremic. He may have had some mild confusion with this foot likely has grade 1 hepatic encephalopathy as well. He was noted to be grossly edematous with anasarca from decompensated acute on chronic cirrhosis without actual coma. He was diuresed accordingly with improvement in his serum sodium and clinical exam. He did not require other interventions. He was noted to have suffered from COVID recently but is improving and just beyond the dating were PACs lobe it may have been indicated. This continued to do well. He is being discharged home today with the caveats that he is requesting early discharge as he is in the process of being evicted from his apartment. Have asked him to seek repeat labs within 1 week.
Age: 32.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incisional drainage, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Developed erythematous streaking, swelling, and worsening pain at injection site. Provided cephalexin  500mg every 6 hours x 5 days w/o improvement. Underwent I&D 08/26/22 due to worsening pain at site. Switched to Bactrim DS BID x 7 days.
Age: 57.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Acne, Chills, Headache, Injection site erythema, Injection site induration
Clinical narrative: Huge red knot at injection site, fever up to 101, chills, body acne, headache
Age: 57.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Pyrexia
Clinical narrative: Huge red knot at injection site, fever up to 101, chills, body acne, headache
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Patient received 3 doses of shingrix instead of 2
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Administration error: parent presented requesting Moderna for dose #2, forgetting they had originally gotten Pfizer for dose #1.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Moderna vaccine was given beyond the manufacturer recommended use time of 30 days at the refrigerated temperature.
Age: 18.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: localized erythema r deltoid erythema measures 2.5 inches by 2 inches and  left deltoid erythema measures 1.5 inches by 1 inch . site red and slightly warm to touch, arm hurts
Age: 1.33
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Administration error: parent presented requesting Moderna for dose #2, forgetting they had originally gotten Pfizer for dose #1
Age: 7.0
Sex: M
Vaccine: TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient and mother came in asking for a tetanus vaccine for school. We administered the Tdap Boostrix vaccine. Patient is 7 years old, and Boostrix is only approved for 10 years and older in a pharmacy.  Spoke with mother, and patient has not reported any side effects
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: This issue might/might not have impacted this individual. We identified a possible storage and handling issue of one particular vial of vaccine that might have made the vaccine less potent on June 16, 2022.  Doses from this vial were given to 9 children on the date June 16, 2022. 17 children were vaccinated that day and we have been unable to identify which 9 children received doses from the vial that was impacted.  The vaccine was reconstituted and replaced into the refrigerator for what inadvertently became too many hours before it was used. We did extensive research with Pfizer, the CDC and the Department of Public Health and have received documentation back from the correct medical unit at the company Pfizer, who researched this vaccine being out of range for possibly 2 additional hours than what they had data for as of June 2022.  Each of the 17 children is being offered an additional dose now, 8 or more weeks after the possibly ?invalid? dose and is encouraged to discuss this with their pediatric primary care provider, who has also been notified by me. We suggested the 8 week delay to potentially reduce the risk of side effects including myocarditis in children after an mRNA if another dose was given sooner. It has now been 8 weeks since that clinic.
Age: 1.5
Sex: M
Vaccine: COVID19
Symptoms: Immune thrombocytopenia, Platelet count increased
Clinical narrative: Patient received COVID vaccine on 8/3.  He developed acute ITP requiring hospitalization on 8/25.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Moderna vaccine was given beyond the manufacturer recommended use time of 30 days at the refrigerated temperature.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Axillary pain, Discomfort, Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: Got 11 yo vaccines on Tuesday. Noticed Wednesday that arm was swollen.  Not sure if it has been progressing or not.   Painful/tender with pressure. Some redness. Mildly uncomfortable when he raises arm - has some axillary soreness. No fever. Not interfering with ADLs
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Tenderness
Clinical narrative: Got 11 yo vaccines on Tuesday. Noticed Wednesday that arm was swollen.  Not sure if it has been progressing or not.   Painful/tender with pressure. Some redness. Mildly uncomfortable when he raises arm - has some axillary soreness. No fever. Not interfering with ADLs
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Pyrexia, Rash, Urticaria
Clinical narrative: Patient received dose# 2 of Pfizer COVID-19 vaccine on 8/15/22 - developed itching ~ 1 hour after vaccine administration, that same day she also went to a water park and was playing in the water, mother says the water smelled funny.She had a fever that night and spots developed all over legs and arms the next day, still very itchy. No other concerns. Patient had an appointment with a provider on 8/19/2022 for this concern. Examination showed that pt had a rash of small hives all over legs and arms, not on face or back. Patient 's parent was advised to use OTC Benadryl every 6 hours as needed for itching; increase fluids; may apply calamine lotion or hydrocortisone cream to rash twice a day. Patient to return to clinic as needed if no improvement or for further concerns. As of the time of this this report, we've not had any further contact from patient's parent.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: Patient came in for a well check and the parent requested the COVID-19 vaccine (Moderna) I had made an error I documented that the patient was 6yrs but the patient was 5yrs. So the patient got a dose of 0.5 mL instead of the normal dose which is 0.25 mL I had given the patient the 6yr-11yr Moderna series 1st dose. I should have given the 6 mon-5yr Moderna series instead. The parent was informed that the patient may have a very sore leg due to the higher dose.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Dosing error.  Child received 0.2ml of the vaccine undiluted
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral
Clinical narrative: Eczema and left shoulder pain
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: Covid 19 documented by positive PCR.  Symptoms: sore throat, headache, cough, fatigue (physical and mental) Paxlovid Recovered @ 19 days with some lingering fatigue and nighttime cough
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Covid 19 documented by positive PCR.  Symptoms: sore throat, headache, cough, fatigue (physical and mental) Paxlovid Recovered @ 19 days with some lingering fatigue and nighttime cough
Age: 39.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Unintended excessive dose- given 0.2mL ID rather than 0.1mL No current adverse reaction
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Dose Error: Child was given 0.2 ml of undiluted vaccine product
Age: 32.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Unintended excessive dose- given 0.2mL ID rather than 0.1mL No current adverse reaction
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Laboratory test, Warm autoimmune haemolytic anaemia
Clinical narrative: Had 3rd Moderna Shot and 3 weeks later was so weak he had to be hospitalized and has developed warm hemolytic anemia.
Age: 63.0
Sex: F
Vaccine: FLUC4
Symptoms: No adverse event
Clinical narrative: Had no adverse event.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: This issue might/might not have impacted this individual. We identified a possible storage and handling issue of one particular vial of vaccine that might have made the vaccine less potent on June 16, 2022.  Doses from this vial were given to 9 children on the date June 16, 2022. 17 children were vaccinated that day and we have been unable to identify which 9 children received doses from the vial that was impacted.  The vaccine was reconstituted and replaced into the refrigerator for what inadvertently became too many hours before it was used. We did extensive research with Pfizer, the CDC and the Department of Public Health and have received documentation back from the correct medical unit at the company Pfizer, who researched this vaccine being out of range for possibly 2 additional hours than what they had data for as of June 2022. Each of the 17 children is being offered an additional dose now, 8 or more weeks after the possibly invalid dose and is encouraged to discuss this with their pediatric primary care provider, who has also been notified by me. We suggested the 8 week delay to potentially reduce the risk of side effects including myocarditis in children after an mRNA if another dose was given sooner. It has now been 8 weeks since that clinic.
Age: 33.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect dose administered
Clinical narrative: Unintended excessive dose- given 0.2mL ID rather than 0.1mL No current adverse reaction
Age: 45.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Unintended excessive dose- given 0.2mL ID rather than 0.1mL No current adverse reaction
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: This issue might/might not have impacted this individual. We identified a possible storage and handling issue of one particular vial of vaccine that might have made the vaccine less potent on June 16, 2022.  Doses from this vial were given to 9 children on the date June 16, 2022. 17 children were vaccinated that day and we have been unable to identify which 9 children received doses from the vial that was impacted.  The vaccine was reconstituted and replaced into the refrigerator for what inadvertently became too many hours before it was used. We did extensive research with Pfizer, the CDC and the local Department of Public Health and have received documentation back from the correct medical unit at the company Pfizer, who researched this vaccine being out of range for possibly 2 additional hours than what they had data for as of June 2022.  Each of the 17 children is being offered an additional dose now, 8 or more weeks after the possibly ?invalid? dose and is encouraged to discuss this with their pediatric primary care provider, who has also been notified by me. We suggested the 8 week delay to potentially reduce the risk of side effects including myocarditis in children after an mRNA if another dose was given sooner. It has now been 8 weeks since that clinic.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Patient had itchy, red arm with bumps at injection site
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: This issue might/might not have impacted this individual. We identified a possible storage and handling issue of one particular vial of vaccine that might have made the vaccine less potent on June 16, 2022.  Doses from this vial were given to 9 children on the date June 16, 2022. 17 children were vaccinated that day and we have been unable to identify which 9 children received doses from the vial that was impacted.  The vaccine was reconstituted and replaced into the refrigerator for what inadvertently became too many hours before it was used. We did extensive research with Pfizer, the CDC and the Department of Public Health and have received documentation back from the correct medical unit at the company Pfizer, who researched this vaccine being out of range for possibly 2 additional hours than what they had data for as of June 2022.  Each of the 17 children is being offered an additional dose now, 8 or more weeks after the possibly ?invalid? dose and is encouraged to discuss this with their pediatric primary care provider, who has also been notified by me. We suggested the 8 week delay to potentially reduce the risk of side effects including myocarditis in children after an mRNA if another dose was given sooner. It has now been 8 weeks since that clinic.
Age: 62.0
Sex: M
Vaccine: FLUC4
Symptoms: No adverse event
Clinical narrative: Had no adverse reaction.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: This issue might/might not have impacted this individual. We identified a possible storage and handling issue of one particular vial of vaccine that might have made the vaccine less potent on June 16, 2022.  Doses from this vial were given to 9 children on the date June 16, 2022. 17 children were vaccinated that day and we have been unable to identify which 9 children received doses from the vial that was impacted.  The vaccine was reconstituted and replaced into the refrigerator for what inadvertently became too many hours before it was used. We did extensive research with Pfizer, the CDC and the Department of Public Health and have received documentation back from the correct medical unit at the company Pfizer, who researched this vaccine being out of range for possibly 2 additional hours than what they had data for as of June 2022.  Each of the 17 children is being offered an additional dose now, 8 or more weeks after the possibly ?invalid? dose and is encouraged to discuss this with their pediatric primary care provider, who has also been notified by me. We suggested the 8 week delay to potentially reduce the risk of side effects including myocarditis in children after an mRNA if another dose was given sooner. It has now been 8 weeks since that clinic.
Age: 0.92
Sex: M
Vaccine: COVID19
Symptoms: Crying, Decreased appetite, Dyspnoea, Fatigue, Fluid intake reduced
Clinical narrative: Mom called concerned stating that patient received 2nd Covid vaccine this morning and is now having trouble breathing. Mom stated that patient was seen on 08/25/2022 for second Covid vaccine and was normal after vaccine that morning. Mom stated that she took patient to daycare afterwards and patient fell asleep on the care ride. Mom said that this was out of character for the patient especially since the patient slept all the way through the night. Mom stated that she dropped patient off at daycare and at 1400 mom received a call from the daycare. According to mom, the daycare told her that the patient was having abnormal breathing and told her to come pick patient up. Mom stated that patient breathing is abnormal but his face has not changed color. Triage nurse listened over the phone to the patient breathing and the patient was grunting with each breath for periods of time and then breathing normally. Mom stated that she believed patient respiration rate is high but every time she set him down to count it, he started crying. Mom denied patient having slow/shallow breathing, cyanosis, retractions, wheezing, or vomiting. Mom stated that patient activity level, eating, and drinking are decreased. Mom stated that she did not know if patient had been regularly urinating and when his last urination was because she had just picked patient up from daycare. Mom stated that patient eyes seemed to be glazed over as if he was taking medications and is more tired than normal. Mom was advised per provider to be seen in the emergency room for further and more immediate evaluation. Outcome is unknown as follow up has not been scheduled and patient was taken local Hospital.
Age: 0.92
Sex: M
Vaccine: COVID19
Symptoms: Grunting, Mobility decreased, Respiratory rate increased, Somnolence
Clinical narrative: Mom called concerned stating that patient received 2nd Covid vaccine this morning and is now having trouble breathing. Mom stated that patient was seen on 08/25/2022 for second Covid vaccine and was normal after vaccine that morning. Mom stated that she took patient to daycare afterwards and patient fell asleep on the care ride. Mom said that this was out of character for the patient especially since the patient slept all the way through the night. Mom stated that she dropped patient off at daycare and at 1400 mom received a call from the daycare. According to mom, the daycare told her that the patient was having abnormal breathing and told her to come pick patient up. Mom stated that patient breathing is abnormal but his face has not changed color. Triage nurse listened over the phone to the patient breathing and the patient was grunting with each breath for periods of time and then breathing normally. Mom stated that she believed patient respiration rate is high but every time she set him down to count it, he started crying. Mom denied patient having slow/shallow breathing, cyanosis, retractions, wheezing, or vomiting. Mom stated that patient activity level, eating, and drinking are decreased. Mom stated that she did not know if patient had been regularly urinating and when his last urination was because she had just picked patient up from daycare. Mom stated that patient eyes seemed to be glazed over as if he was taking medications and is more tired than normal. Mom was advised per provider to be seen in the emergency room for further and more immediate evaluation. Outcome is unknown as follow up has not been scheduled and patient was taken local Hospital.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: This issue might/might not have impacted this individual. We identified a possible storage and handling issue of one particular vial of vaccine that might have made the vaccine less potent on June 16, 2022.  Doses from this vial were given to 9 children on the date June 16, 2022. 17 children were vaccinated that day and we have been unable to identify which 9 children received doses from the vial that was impacted.  The vaccine was reconstituted and replaced into the refrigerator for what inadvertently became too many hours before it was used. We did extensive research with Pfizer, the CDC and the Department of Public Health and have received documentation back from the correct medical unit at the company Pfizer, who researched this vaccine being out of range for possibly 2 additional hours than what they had data for as of June 2022.  Each of the 17 children is being offered an additional dose now, 8 or more weeks after the possibly ?invalid? dose and is encouraged to discuss this with their pediatric primary care provider, who has also been notified by me. We suggested the 8 week delay to potentially reduce the risk of side effects including myocarditis in children after an mRNA if another dose was given sooner. It has now been 8 weeks since that clinic.
Age: 64.0
Sex: F
Vaccine: FLUC4
Symptoms: No adverse event
Clinical narrative: Had no adverse reaction.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, C-reactive protein increased, COVID-19, Cardiac imaging procedure normal, Cardiac stress test
Clinical narrative: Chest pain started the night after taking the vaccine.I have had from 5-25 episodes a day lasting anywhere from 5-45 seconds and ranging in pain severity. Starts as burning sensation and then becomes sharp. Started to have high blood pressure as well. Started having dizziness and headaches. Have had the chest pains every day since the vaccine. Was put on anti inflammatory medication and blood pressure medication.  Pain got better with medication and blood pressure medication was increased do to continuing to have high blood pressure.  In May of 2022 I felt much better, then  early June got Covid and inflammation went back high again and my pain increased significantly.  I?m back on anti inflammatory medication and continuing to limit my physical activity per my doctor. My treatment physically initially was to take it easy and let the inflammation come down. After that was not helping, was put on the anti inflammatoeynmedication.  Am currently on anti inflammatory medication with limited physical activity.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chest pain, Dizziness, Electrocardiogram, Headache
Clinical narrative: Chest pain started the night after taking the vaccine.I have had from 5-25 episodes a day lasting anywhere from 5-45 seconds and ranging in pain severity. Starts as burning sensation and then becomes sharp. Started to have high blood pressure as well. Started having dizziness and headaches. Have had the chest pains every day since the vaccine. Was put on anti inflammatory medication and blood pressure medication.  Pain got better with medication and blood pressure medication was increased do to continuing to have high blood pressure.  In May of 2022 I felt much better, then  early June got Covid and inflammation went back high again and my pain increased significantly.  I?m back on anti inflammatory medication and continuing to limit my physical activity per my doctor. My treatment physically initially was to take it easy and let the inflammation come down. After that was not helping, was put on the anti inflammatoeynmedication.  Am currently on anti inflammatory medication with limited physical activity.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Inflammation
Clinical narrative: Chest pain started the night after taking the vaccine.I have had from 5-25 episodes a day lasting anywhere from 5-45 seconds and ranging in pain severity. Starts as burning sensation and then becomes sharp. Started to have high blood pressure as well. Started having dizziness and headaches. Have had the chest pains every day since the vaccine. Was put on anti inflammatory medication and blood pressure medication.  Pain got better with medication and blood pressure medication was increased do to continuing to have high blood pressure.  In May of 2022 I felt much better, then  early June got Covid and inflammation went back high again and my pain increased significantly.  I?m back on anti inflammatory medication and continuing to limit my physical activity per my doctor. My treatment physically initially was to take it easy and let the inflammation come down. After that was not helping, was put on the anti inflammatoeynmedication.  Am currently on anti inflammatory medication with limited physical activity.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Pharmacist administered dose from Pfizer Covid 5-11 vaccine vial WITHOUT DILUTING with the required 1.3ml normal saline. By my calculations, patient received dose of 23mcg instead of the appropriate 10mcg active ingredients. CDC consulted.  I was informed that patient was more likely to have soreness at injection site, but not at increased risk of any other serious side effects.  Mother of patient was informed.  Counselled regarding increased risk of sore arm, and recommended acetaminophen to treat if it occurred.  Will follow up in three days to confirm no further ill effects.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was 5 years old when patient received Covid Vaccine for 6 months- 4 years old.
Age: 15.0
Sex: F
Vaccine: UNK
Symptoms: Syncope
Clinical narrative: Patient experienced syncope about 5 minutes following the administration of the vaccine. She was seated when it occured. She said she felt normal after a couple of minutes of remaining seated.
Age: 20.0
Sex: F
Vaccine: PNC20
Symptoms: Wrong product administered
Clinical narrative: Patient came in to get meningitis vaccine and received Prevnar20 instead of the meningitis vaccine by mistake
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: The vaccination was billed as toddler. What was given was the Pfizer pediatric vaccination. This was discovered after the parents had left the building.
Age: 2.0
Sex: M
Vaccine: IPV
Symptoms: Eczema, Rash, Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: Pt received polio vaccine 8/5/22 and that evening, he developed rash on B legs/buttocks Photos sent show red raised papular rash After a few days eczematous, very pruritic rash erupted and spread from legs to abdomen The abdominal rash has improved ; B legs still with rash and very itchy No reaction seen after first polio vaccine dose
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient was given undiluted vaccine
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient was given undiluted vaccine
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Malaise, Mass, Skin warm
Clinical narrative: Extremely large red, solid and hot lump that has grown in size since injection. In addition to feeling very sick.
Age: 26.0
Sex: M
Vaccine: FLU4
Symptoms: Bell's palsy
Clinical narrative: Pt woke up day after vaccine with bell's palsy symptoms, he went to ER where he was diagnosed and treated with steroids and antivirals. Pt states it is "mild case" and he has a follow up scheduled with his doctor.
Age: 1.25
Sex: M
Vaccine: DTAP
Symptoms: Rash
Clinical narrative: Patient got DTAP vaccine and rash started all over patients body the next morning and lasted 2-3 days. After first DTAP, patient developed small rash on legs according to mother.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient was given undiluted COVID Vaccine.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, Middle ear effusion, Pain in extremity
Clinical narrative: My arm was more sore than the first one. I also had water in one of my ear. I went to the doctor and she prescribed me nose spray for my ear. This affects my speech. This has never happened to me before. My doctor thinks it is allergies and doesn't think it has anything to do with the shot.